Tracey Perry

698 total citations
10 papers, 360 citations indexed

About

Tracey Perry is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Tracey Perry has authored 10 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in Tracey Perry's work include Cancer Research and Treatments (3 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (2 papers). Tracey Perry is often cited by papers focused on Cancer Research and Treatments (3 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (2 papers). Tracey Perry collaborates with scholars based in United Kingdom, Hong Kong and Czechia. Tracey Perry's co-authors include Pamela Kearns, Francis Mussai, Carmela De Santo, Paul Cheng, Andrew D. Beggs, Sharon A. Egan, Ciarán Woodman, Margaret H.L. Ng, Anthony W.I. Lo and Guy Pratt and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Tracey Perry

9 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tracey Perry United Kingdom 7 195 113 103 87 74 10 360
Francesca Alvarez‐Calderon United States 9 239 1.2× 141 1.2× 75 0.7× 65 0.7× 47 0.6× 12 438
Zuzanna Rydzyńska Poland 5 114 0.6× 21 0.2× 79 0.8× 123 1.4× 269 3.6× 8 413
Johannes Schmoellerl Austria 6 226 1.2× 63 0.6× 83 0.8× 96 1.1× 38 0.5× 11 354
Sonia Zaghdoudi France 4 142 0.7× 54 0.5× 70 0.7× 95 1.1× 50 0.7× 4 256
Osnat Alsheich-Bartok Australia 9 325 1.7× 34 0.3× 57 0.6× 201 2.3× 42 0.6× 9 393
Scott E. Millman United States 6 234 1.2× 54 0.5× 84 0.8× 83 1.0× 54 0.7× 10 313
Theodore Evan United Kingdom 5 159 0.8× 20 0.2× 97 0.9× 107 1.2× 21 0.3× 7 244
Fengbiao Zhou China 11 303 1.6× 24 0.2× 102 1.0× 90 1.0× 57 0.8× 23 367
Tracy E. Garrett United States 8 212 1.1× 66 0.6× 24 0.2× 275 3.2× 109 1.5× 10 403
Satoko Shimamura United Kingdom 4 264 1.4× 33 0.3× 62 0.6× 84 1.0× 24 0.3× 5 373

Countries citing papers authored by Tracey Perry

Since Specialization
Citations

This map shows the geographic impact of Tracey Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracey Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracey Perry more than expected).

Fields of papers citing papers by Tracey Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracey Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracey Perry. The network helps show where Tracey Perry may publish in the future.

Co-authorship network of co-authors of Tracey Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Tracey Perry. A scholar is included among the top collaborators of Tracey Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracey Perry. Tracey Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Perry, Tracey, Katerina Vrzalikova, Matthew Pugh, et al.. (2024). The Oncogenic Lipid Sphingosine-1-Phosphate Impedes the Phagocytosis of Tumor Cells by M1 Macrophages in Diffuse Large B Cell Lymphoma. Cancers. 16(3). 574–574. 5 indexed citations
2.
Reed, Michelle A.C., Jennie Roberts, Sandeep Potluri, et al.. (2024). The glutamate/aspartate transporter EAAT1 is crucial for T-cell acute lymphoblastic leukemia proliferation and survival. Haematologica. 109(11). 3505–3519.
3.
Moriconi, Chiara, Tracey Perry, Paula Cunnea, et al.. (2024). 1283 Oncolytic immunotherapy THEO-260 enters readiness for first in human clinical trial in ovarian cancer patients. Regular and Young Investigator Award Abstracts. A1438–A1438. 1 indexed citations
4.
Vrzalikova, Katerina, Maha Ibrahim, Eszter Nagy, et al.. (2018). Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma. Cancers. 10(9). 285–285. 20 indexed citations
5.
Mussai, Francis, Rachel Wheat, Sarah Booth, et al.. (2018). Targeting the arginine metabolic brake enhances immunotherapy for leukaemia. International Journal of Cancer. 145(8). 2201–2208. 60 indexed citations
6.
Santo, Carmela De, Sarah Booth, Tracey Perry, et al.. (2017). The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated‐recombinant arginase I BCT‐100. International Journal of Cancer. 142(7). 1490–1502. 53 indexed citations
7.
Mussai, Francis, Sharon A. Egan, Tracey Perry, et al.. (2015). Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target. Blood. 125(15). 2386–2396. 126 indexed citations
8.
Perry, Tracey, Sarah Berhane, Ceri Oldreive, et al.. (2014). The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53. Oncogene. 34(25). 3336–3348. 6 indexed citations
9.
Leonard, Sarah, Tracey Perry, Ciarán Woodman, & Pamela Kearns. (2014). Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia. PLoS ONE. 9(1). e87475–e87475. 26 indexed citations
10.
Costa, David Da, Angelo Agathanggelou, Tracey Perry, et al.. (2013). BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia. Blood Cancer Journal. 3(7). e126–e126. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026